Michael Garkavij

177Lu‐[DOTA0,Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy

Michael Ljungberg, Sven-Erik Strand, M. Ljungberg, 2010, Cancer.

A novel platform for radioimmunotherapy: extracorporeal depletion of biotinylated and 90Y-labeled rituximab in patients with refractory B-cell lymphoma.

Michael Ljungberg, Bengt Sandberg, Tomas Ohlsson, 2005, Cancer biotherapy & radiopharmaceuticals.